Schrodinger, Inc. Gross Profit 2019-2024 | SDGR
Schrodinger, Inc. gross profit from 2019 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| Schrodinger, Inc. Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $141 |
| 2022 | $101 |
| 2021 | $66 |
| 2020 | $63 |
| 2019 | $49 |
| 2018 | $43 |
| Schrodinger, Inc. Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $18 |
| 2024-06-30 | $31 |
| 2024-03-31 | $19 |
| 2023-12-31 | $58 |
| 2023-09-30 | $24 |
| 2023-06-30 | $14 |
| 2023-03-31 | $46 |
| 2022-12-31 | $39 |
| 2022-09-30 | $17 |
| 2022-06-30 | $17 |
| 2022-03-31 | $28 |
| 2021-12-31 | $26 |
| 2021-09-30 | $11 |
| 2021-06-30 | $12 |
| 2021-03-31 | $16 |
| 2020-12-31 | $19 |
| 2020-09-30 | $15 |
| 2020-06-30 | $14 |
| 2020-03-31 | $16 |
| 2019-12-31 | $16 |
| 2019-09-30 | $11 |
| 2019-06-30 | $10 |
| 2019-03-31 | $13 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MEDICAL INFO SYS | $1.650B | $0.217B |
| Schr?dinger Inc. provides computational platforms to accelerate drug discovery and materials design deployed by biopharmaceutical and industrial companies, academic institutions and government laboratories. Schr?dinger Inc. is based in NEW YORK. | |||